Irish Life Investment Managers’s Alexion Pharmaceuticals ALXN Stock Holding History

Irish Life Investment Managers’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$6.98M	Buy	+75,717	New	+$7.3M	0.09%	240

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Irish Life Investment Managers's ALXN Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Alexion Pharmaceuticals (ALXN) in Q2 2013: 75,717 shares worth $6.98M. The stake represents 0.09% of the portfolio and ranks #240 among its holdings.

406 funds tracked by Wall St. Rank hold ALXN as of Q2 2013.

Irish Life Investment Managers held 75,717 shares of Alexion Pharmaceuticals worth $6.98M as of Q2 2013.
Alexion Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Alexion Pharmaceuticals made up 0.09% of Irish Life Investment Managers's portfolio in Q2 2013, its #240 holding.
406 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.